Organogenesis (ORGO) Q1 2025 Earnings Call May 08, 2025 05:00 PM ET Company Participants Gary Gillheeney, Sr - Director, President, CEO & Chair of the BoardDavid Francisco - Chief Financial OfficerAaron Wukmir - Healthcare Equity Research Associate Conference Call Participants Ryan Zimmerman - Managing Director & Medical Technology AnalystRoss Osborn - Director, Lead Research Analyst - MedTech and Diagnostics Operator Welcome, ladies and gentlemen, to the First Quarter twenty twenty five Earnings Conference ...

Organogenesis (ORGO) Q1 2025 Earnings Call May 08, 2025 05:00 PM ET Speaker0 Welcome, ladies and gentlemen, to the First Quarter twenty twenty five Earnings Conference Call for Organogenesis Holdings, Inc. At this time, all participants have been placed in a listen only mode. Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly. Before we begin, I would like to remind everyone that our remarks today may contain forward l ...

An independently validated study highlighted K12 Tutoring’s success in personalized, academic supportReston, VA, April 30, 2025 (GLOBE NEWSWIRE) -- K12 Tutoring, a leading personalized online tutoring service, has earned Level II validation under the Every Student Succeeds Act (ESSA), confirming a strong, evidence-based link between the platform’s use and positive student outcomes. This recognition underscores K12 Tutoring’s role as an effective academic intervention, providing schools and districts with re ...

WAYNE, Pa., April 30, 2025 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of an expansion to the Indications for Use of the QuikClot Control+™ Hemostatic Device to include all grades of internal and external bleeding. The QuikClot Control+™ Device was previously indicated for temporary control of class III and class IV internal organ space bleeding, severely bleeding surgical w ...

Premier (PINC) Q2 2025 Earnings Call February 04, 2025 08:00 AM ET Company Participants Benjamin Krasinski - Director, Investor RelationsMichael Alkire - President & CEOGlenn Coleman - CFO & CAOKevin Caliendo - Managing DirectorRichard Close - Managing DirectorBill Sutherland - Director of Research Conference Call Participants Michael Cherny - Senior Managing Director & Senior Research AnalystEric Percher - Research Analyst - Pharma Supply Chain and HCITEric Coldwell - Senior Research AnalystJessica Tassan ...